Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease

Archives of Neurology

Volumn 53, Issue 4, 1996, Pages 316-324

  Harris, Gordon J ^a   Aylward, Elizabeth H ^b   Peyser, Carol E ^c   Pearlson, Godfrey D ^b   Brandt, Jason ^b   Roberts Twillie, Joy V ^b   Barta, Patrick E ^b   Folstein, Susan E ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BASAL GANGLION; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN SCINTISCANNING; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUNTINGTON CHOREA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUTAMEN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0029987151     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1996.00550040044013     Document Type: Article

References (57)

1. Bruyn GW. Huntington's chorea, historical, clinical and laboratory synopsis. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology. Amsterdam, the Netherlands: North-Holland Publishing; 1968:298-378
2. Folstein SE. Huntington's Disease. A Disorder of Families. Baltimore, Md: Johns Hopkins University Press, 1989.
3. Roos RAC, Pruyt JFM, deVries J, Bots GTA. Neuronal distribution in the putamen in Huntington's disease. J Neurol Neurosurg Psychiatry. 1985;48:422-425.
4. Vonsattel JP, Meyers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP. Neuropathologic classification of Huntington's disease. J Neuropathol Exp Neurol 1985;44 559-577
5. Carrosco LH, Mukherji CS, Atrophy of the corpus striatum in normal male at risk of Huntington's chorea. Lancet. 1986;1:1388-1389.
6. Peyser CE, Folstein MF, Chase GA, et al. Trial of D-α-toeopherol in Huntington's disease Am J Psychiatry. 1995;152:1771-1775
7. Smith FW, Gemmell HG, Sharp PF, Besson JA. Technetium-99m HMPAO imaging in patients with basal ganglia disease Br J Radiol. 1988;61:914-920.
8. Leblhuber J, Hoell K, Reisecher F, et al. Single photon emission computed tomography in Huntington's chorea Psychiatry Res. 1989;29:337-339.
9. Reid IC, Besson JA, Best PV, Sharp PF, Gemmell HG, Smith FW Imaging of cerebral blood flow markers in Huntington's disease using single photon emission computed tomography J Neurol Neurosurg Psychiatry. 1988;51:1264-1268.
10. Hasselbach SG, Oberg G, Sorensen SA, et al Reduced regional cerebral blood flow in Huntington's disease studied by SPECT J Neurol Neurosurg Psychiatry 1992;55 1018-1023.
11. Pantano P, Lenzi GL, Berardelli A, Passafiume D, Possilli C, DiPiero V. Regional CBF pattern in patients with Huntington's disease. J Cereb Blood Flow Metab. 1989;9(suppl 1):S22. Abstract
12. Young AB, Penney JB, Starosta-Rubinstein S, et al. PET scan investigations of Huntington's disease, cerebral metabolic correlates of neurological features and functional decline Ann Neurol. 1986;20 296-303
13. Kuwert T, Lange HW, Langen KJ, Herzog H, Aulich A, Feinendegen LE Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain. 1990;113:1405-1423.
14. Martin WR, Clark G, Ammann W, Stoessl AJ, Shtybel W, Hayden MR Cortical glucose metabolism in Huntington's disease. Neurology. 1992;42:223-229.
15. Berent S, Giordani B, Lehtinen S, et al Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function Ann Neurol. 1988;23:541-546.
16. Kuwert T, Lange HW, Langen KJ, Herzog H, Aulich A, Feinendegen LE. Cerebral glucose consumption measured by PET in patients with and without psychiatric symptoms of Huntington's disease. Psychiatry Res. 1989;29:361-362.
17. Kuhl DE, Phelps ME, Markham CH, Metter EJ, Riege WH, Winter J. Cerebral metabolism and atrophy in Huntington's disease determined by 18-FDG and computed tomographic scan Ann Neurol. 1982;12:425-434.
18. Hayden MR, Martin WR, Stoessl AJ, et al. Positron emission tomography in the early diagnosis of Huntington's disease. Neurology. 1986;36:888-894.
19. Garnett ES, Firnau G, Nahmias C, Carbotte R, Bartolucci G. Reduced striatal glucose consumption and prolonged reaction time are early features in Huntington's disease. J Neurol Sci. 1984;65:231-237.
20. Young AB, Penney JB, Starosta-Rubinstein S, et al. Normal caudate glucose metabolism in persons at risk for Huntington's disease Arch Neurol. 1987; 44:254-257.
21. Hayden MR, Hewitt J, Stoessl AJ, Clark C, Ammann W, Martin WR The combined use of positron emission tomography and DNA polymorphisms for pre-clinical detection of Huntington's disease Neurology. 1987;37:1441-1447.
22. Mazziotta JC, Phelps ME, Pahl JJ, et al. Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease N Engl J Med. 1987; 316:357-362
23. Starkstein SE, Folstein SE, Brandt J, Pearlson GD, McDonnell A, Folstein M. Brain atrophy in Huntington's disease: a CT-scan study. Neuroradiology. 1989; 31:156-159
24. Oepen G, Ostertag CH. Diagnostic value of CT in patients with Huntington's chorea and their offspring. J Neurol. 1981;225:189-196.
25. Sax DS, O'Donnell B, Butters N, Menzer L, Montgomery K, Kayne HL. Computed tomographic, neurologic and neuropsychological correlates of Huntington's disease Int J Neurosci. 1983;18:21-36.
26. Starkstein SE, Brandt J, Folstein S, et al. Neuropsychological and neuroradiological correlates in Huntington's disease. J Neurol Neurosurg Psychiatry. 1988; 51:1259-1263
27. Bamford KA, Caine ED, Kido DK, Plassche WM, Shoulson I Clinical-pathologic correlation in Huntington's disease: a neuropsychological and computed tomography study. Neurology. 1989;39:796-801
28. Barr AN, Heinze WJ, Dobben GD, Valvassori GE, Sugar O Bicaudate index in computerized tomography of Huntington's disease and cerebral atrophy Neurology. 1978;28:1196-1200.
29. Harris GJ, Pearlson GD, Peyser CE, et al Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease. Ann Neurol. 1992;31:69-75.
30. Jernigan TL, Salmon DP, Butters N, Hesselink JR Cerebral structure on MRI, II: specific changes in Alzheimer's and Huntington's diseases. Biol Psychiatry. 1991;29 68-81
31. Aylward EH, Brandt J, Codon AM, Mangus RS, Barta PE, Harris GJ Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons. Neurology. 1994;44 823-828
32. Pearlson GD, Harris GJ, Powers RE, et al. Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. Arch Gen Psychiatry. 1992;49:402-408.
33. Spitzer RL, Williams JBW, Gibbon N, First MB. Structured Clinical Interview for DSM-III-R - Patient Edition (SCID-P, Version 1.0). Washington, DC: American Psychiatric Press, 1990
34. Folstein SE, Leigh JR, Parhad IM, Folstein MF. The diagnosis of Huntington's disease. Neurology. 1986;36:1279-1283.
35. Folstein SE, Jensen B, Leigh JR, Folstein MF. The measurement of abnormal movement: methods developed for Huntington's disease. Neurobehav Toxicol Teratology. 1983;5:605-609.
36. Folstein MF, Folstein SE, McHugh PR. 'Mini Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
37. Winchell HS, Horst WD, Braun L, Oldendorf WH, Hattnar R, Parker H. N-isopropyl-[123-I] p-iodoamphetamine, single-pass uptake and washout, binding to brain synaptosomes, and localization in dog and monkey brain. J Nucl Med. 1980; 21:947-952.
38. Kuhl DE, Barrio JR, Huang SC, et al. Quantifying local cerebral blood flow by N-isopropyl-p-[123-I] iodoamphetamine (IMP) tomography. J Nucl Med 1982; 23:196-203.
39. Von Schulthess GK, Ketz E, Schubiger PA, Bekier A. Regional quantitative non-invasive assessment of cerebral perfusion and function with N-isopropyl-[123-I] p-iodoamphetamine. J Nucl Med. 1985;26:9-16.
40. Harris GJ, Pearlson GD. MRI-guided region of interest placement on emission computed tomograms Psychiatry Res. 1993;50:57-63.
41. Harris GJ, Links JM, Pearlson GD, Gamargo EE Cortical circumferential profile of SPECT cerebral perfusion in Alzheimer's disease. Psychiatry Res. 1991; 40:167-180.
42. Harris GJ, Rhew EH, Noga T, Pearlson GD. User-friendly method for rapid brain and CSF volume calculation using transaxial MRI images. Psychiatry Res. 1991; 40:61-68.
43. Starkstein SE, Brandt J, Bylsma F, Peyser C, Folstein M, Folstein SE. Neuropsychological correlates of brain atrophy in Huntington's disease: a magnetic resonance imaging study. Neuroradiology. 1992;34:487-489.
44. Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-276.
45. Benton AL. The Revised Visual Retention Test. 4th ed. New York, NY: Psychological Corp, 1974
46. Stroop JR Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18:643-662
47. Morris JC, Heyman A, Mohs RC The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), I. clinical and neuropsychological assessment of Alzheimer's disease Neurology. 1989;39:1159-1165
48. Nelson HE. A modified card sorting test sensitive to frontal lobe defects. Cortex. 1976;12:313-324.
49. Wechsler D Wechsler Adult Intelligence Scale Manual New York, NY: Psychological Corp; 1955.
50. Stuss DT, Benson DF. The Frontal Lobes. New York, NY: Raven Press; 1986.
51. Benton AL. Differential behavioral effects in frontal lobe disease. Neuropsychology. 1968;6:53-60.
52. Lange H, Thorner G, Hopf A, Schroder KF. Morphometric studies of the neuropathological changes in choreatic diseases. J Neurol Sci. 1976;28:401-425.
53. Lange HW. Quantitative changes of telencephalon, diencephalon, and mesencephalon in Huntington's chorea, postencephalitic, and idiopathic parkinsonism Verh Anat Ges. 1981;75:S.923-S.925.
54. De la Monte SM, Vonsattel JP, Richardson EP. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol. 1988;47:516-525.
55. Aylward EH, Schwartz J, Machlin S, Pearlson G. Bicaudate ratio as a measure of caudate volume in magnetic resonance imaging. Am J Neuroradiol. 1991; 12:1217-1222
56. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci. 1986;9 357-381.
57. DeLong MR, Alexander GE, Miller WC, Crutcher MD. Anatomical and functional aspects of basal ganglia-thalamocortical circuits. In: Franks AJ, Ironside JW, Mindham RHS, Smith RJ, Spokes EGS, Winslow W, eds. Function and Dysfunction in the Basal Ganglia Manchester, England: Manchester University Press, 1990:3-34